Vaxart, Inc.: Form 10-K for the period ended Jun 30, 2016
Filed with the SEC on Sep 13, 2016 and accepted by EDGAR at Sep 13, 2016, 17:14 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2016-04-01 to 2016-06-30 | $600.0k | us-gaap:Revenues |
| Revenue | 12 months2015-07-01 to 2016-06-30 | $9.3m | us-gaap:Revenues |
| Cost of revenue | 3 months2016-04-01 to 2016-06-30 | $7.4m | us-gaap:CostOfRevenue |
| Research and development | 12 months2015-07-01 to 2016-06-30 | $26.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2015-07-01 to 2016-06-30 | −$25.2m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2016-04-01 to 2016-06-30 | −$7.1m | us-gaap:NetIncomeLoss |
| Net income | 12 months2015-07-01 to 2016-06-30 | −$25.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2016-04-01 to 2016-06-30 | −$0.18 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2015-07-01 to 2016-06-30 | −$0.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2016-04-01 to 2016-06-30 | −$0.18 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2015-07-01 to 2016-06-30 | −$0.66 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2015-07-01 to 2016-06-30 | 38,635,452 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2015-07-01 to 2016-06-30 | −$14.1m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2015-07-01 to 2016-06-30 | $200.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2016-06-30 | $49.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2016-06-30 | $72.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2016-06-30 | $72.7m | us-gaap:Assets |
| Current liabilities | At period end2016-06-30 | $9.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2016-06-30 | $26.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2016-06-30 | $46.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-16-038645. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.